X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-4-2023-22726.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211995
https://www.prnewswire.com/news-releases/tolmar-announces-acquisition-of-jatenzo-testosterone-undecanoate-for-the-treatment-of-hypogonadism-to-expand-its-market-leading-urology-portfolio-301662003.html
https://www.globenewswire.com/news-release/2022/10/18/2536906/19989/en/Clarus-Therapeutics-Holdings-Inc-Announces-Completion-of-Auction-for-Sale-of-JATENZO-and-Selection-of-Tolmar-Inc-as-Successful-Bidder.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-10-2022-1660649426.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-22-2021-1640158210.pdf
https://www.prnewswire.com/news-releases/centers-for-medicare-and-medicaid-services-cms-issues-permanent-j-code-for-tolmars-fensolvi-effective-july-1-2021-301290132.html
https://www.prnewswire.com/news-releases/tolmar-publishes-study-in-the-february-issue-of-journal-of-urology-on-the-impact-of-late-dosing-on-testosterone-suppression-with-two-different-leuprolide-acetate-formulations-in-situ-gel-and-microsphere--an-analysis-of-us-clinic-301266673.html
https://www.prnewswire.com/news-releases/tolmar-publishes-study-in-the-february-issue-of-journal-of-urology-on-the-impact-of-late-dosing-on-testosterone-suppression-with-two-different-leuprolide-acetate-formulations-in-situ-gel-and-microsphere--an-analysis-of-us-clinic-301266673.html
https://www.prnewswire.com/news-releases/tolmar-affirms-supply-of-fensolvi-leuprolide-acetate-for-pediatric-patients-with-central-precocious-puberty-301114208.html#:~:text=BUFFALO%20GROVE%2C%20Ill.%2C%20Aug,central%20precocious%20puberty%20(CPP).
Market Place
Share 
